UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8‑K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

August 22, 2017


AXT, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-24085

 

94-3031310

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

4281 Technology Drive

Fremont, California 94538

(Address of principal executive offices, including zip code)

 

(510) 438-4700

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

[  ] Emerging growth company

[  ] If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

 


 

 

Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(c)

On July 24, 2017, the Board of Directors (the “Board”) of AXT, Inc. (the “Company”) appointed Wilson Lin, Ph.D., 48, to serve as the Chief Operating Officer of the Company, effective as of the date he first commenced employment with the Company, which is August 21, 2017.  The Company issued a press release, dated August 22, 2017, regarding the appointment of Dr. Lin as Chief Operating Officer of the Company.

Prior to joining the Company, Dr. Lin served as director and Chief Executive Officer of General Photonics Corporation, a manufacturer of advanced optical polarization modules and instruments, from July 2016 to August 2017.  Prior to General Photonics, Dr. Lin held various management positions of increasing responsibility at Newport Corporation, a worldwide leader in photonics solutions, from December 2006 to June 2016, most recently as Vice President, Asia Pacific.  Dr. Lin holds a Ph.D. in physics from the City University of New York, an M.B.A. degree from the UCLA Anderson School of Management and a B.S. degree in physics from Chun-Yuan University, Taiwan.

There are no arrangements or understandings between Dr. Lin and any other persons pursuant to which he was selected as an officer, he has no family relationships with any of the Company’s directors or executive officers and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

The Company entered into an employment offer letter, dated as of July 10, 2017 (the “Agreement”), with Dr. Lin. The Agreement has no specified term, and Dr. Lin’s employment with the Company will be on an at-will basis. The material terms of the Agreement are summarized below.

Dr. Lin’s initial base salary will be $300,000 per year (the “Base Salary”) and his target bonus opportunity for 2017 will be fifty percent (50%) of his Base Salary (excluding any Salary Premium, discussed below), but with such 2017 bonus prorated based on the period during 2017 he is employed with the Company.  While Dr. Lin is employed with the Company and the majority of work is based in China (the “Assignment Period”), during the one‑year period after he starts employment with the Company (the “Start Date” and such period, the “Initial Assignment Period”), the Company will provide Dr. Lin a salary premium equal to ten percent (10%) of his Base Salary (the “Salary Premium”).  During the Initial Assignment Period, Dr. Lin also will be eligible to receive a per diem benefit of $50 per day, payable in accordance with the Company’s expatriate policy. 

The Agreement provides Dr. Lin a $40,000 sign‑on bonus, which will be subject to repayment by him if, within one year of his Start Date either he resigns for any reason or the Company terminates his employment for Cause (as such term is defined in the Agreement).  During the Assignment Period, Dr. Lin will receive tax equalization benefits for the Assignment Period in the event that he is subject to income tax in both China and the U.S.  The Company will provide Dr. Lin up to twelve (12), Company‑paid, round trip airplane tickets for travel for himself (or up to three (3) such round‑trip tickets for immediately family) between China and his California residence each year during the Assignment Period. 

The Agreement provides for the grant of a restricted stock award covering 120,000 shares of the Company’s common stock (the “RSA”) under the Company’s 2015 Equity Incentive Plan and the RSA award agreement.  The RSA will be scheduled to vest as to twenty-five percent (25%) of the RSA on each of the one, two, three and four year anniversaries of the vesting commencement date, subject to Dr. Lin’s continued employment with the Company. 

If Dr. Lin’s employment with the Company is terminated by the Company without Cause and not as a result of his death or disability, then subject to Dr. Lin entering into and not revoking a separation agreement and release of claims in favor of the Company (the “Release”), he will receive:  (a) cash severance equal to 12 months of his then Base Salary (excluding any Salary Premium), and (b) up to 12 months of Company-paid COBRA premiums to continue his group health insurance coverage for himself and his eligible dependents.  If Dr. Lin’s employment with the Company is terminated by the Company without Cause and such termination occurs upon or within 12 months following a Change in Control (as such term is defined in 2015 Plan), then subject to Dr. Lin entering into and not revoking the Release, and in addition to the foregoing severance benefits, any unvested and outstanding portion of his then outstanding equity awards will accelerate vesting in full.


 

The foregoing description of the Agreement is qualified in its entirety by reference to the full text of the Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.  The Company and Dr. Lin intend to enter into the Company’s standard form of indemnification agreement, which was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 31, 2014 and is incorporated by reference herein.

 

Item 7.01.  Regulation FD Disclosure.

 

The Company issued a press release, dated August 22, 2017, regarding the appointment of Dr. Lin as Chief Operating Officer of the Company.  The press release is furnished herewith as Exhibit 99.1.

 

The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

Item 9.01.  Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

 

10.1 Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin.

99.1 Press Release, dated August 22, 2017.


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

AXT, Inc.

 

 

 

 

By:

/s/ Gary L. Fischer

 

 

 

Gary L. Fischer

Chief Financial Officer and Corporate Secretary

 

Date: August 22, 2017

 

 


Exhibit 10.1

Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin

 

PICTURE 1   4281 Technology Drive    Fremont, CA 94538   Ph: 510-438-4700 www.axt.com

 

July 10, 2017

 

Dr. Wilson Lin

7123 Linden Terrace

Carlsbad, California, 92011

 

 

Dear Wilson,

 

We are very excited to have you join the AXT team and we look forward to working with you.  This letter confirms our offer of employment with AXT, Inc. (“AXT”).

 

1.

Employment and Duties

You will be employed by AXT as its Chief Operating Officer, reporting to AXT’s Chief Executive Officer (“CEO”), Dr. Morris Young.  Your duties and responsibilities will be assigned to you from the CEO.  These responsibilities and duties may change over time.  Your principal place of employment will be Carlsbad, California but you will be expected to spend approximately 70% of your working time traveling, primarily to be at Tongmei.

 

2.

Start Date

If you accept this offer, you will assume your new position on a date mutually agreeable between you and AXT, but in any event not later than September 1, 2017 (the date you actually commence employment with AXT, the “Start Date”).

 

3.

Base Salary

In consideration of your services to AXT, you will receive a starting base salary equal to twenty-five thousand dollars ($25,000.00) per month ($ 300,000 per year on an annualized basis) (“Base Salary”), which will be payable in accordance with AXT’s normal payroll practices subject to applicable withholdings, and subject to adjustment by AXT’s Board of Directors (the “Board”) from time to time.  AXT currently processes payroll every two weeks. 

 

4.

Salary Premium

While you are employed with AXT and the majority of your duties and responsibilities are China‑based (“Assignment Period”) during the period beginning on the date you start employment with AXT (the “Start Date”) through the one (1) year anniversary of your Start Date (the “Initial Assignment Period”), AXT will provide a salary premium of ten percent (10%) of your Base Salary (the “Salary Premium”), which will be payable in accordance with AXT’s normal payroll practices and subject to applicable withholdings.  To the extent that the Assignment Period continues after expiration of such Initial Assignment Period, AXT will determine, in good faith in its sole discretion, any continuation thereafter of the Salary Premium.  Any Salary Premium will be subject to the terms and conditions of AXT’s expatriate policy   as may be in effect from time to time. 

 

5.

Per Diem

During the Initial Assignment Period, you will be eligible to receive a per diem benefit of fifty dollars ($50) per day, payable on a monthly basis and subject to the terms and conditions of AXT’s Expatriate Policy as may be in effect from time to time.    This allowance is intended to be used by you to pay the rent on your apartment in China, for food and

 


 

Exhibit 10.1

Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin

 

general other costs and expenses incurred because you are living in China.  The amount will be paid to you monthly by Tongmei.  During the Initial Assignment Period, this will total $18,250 ($50 times 365 days).  To the extent that the Assignment Period continues after expiration of the Initial Assignment Period, AXT will determine, in good faith in its sole discretion, any continuation thereafter of the Per Diem Benefit. 

 

6.

Equity Award

Subject to our Board’s approval ,  you will be granted a restricted stock award covering 120,000 shares of AXT’s common stock (the “RSA”) pursuant to the terms of AXT’s 2015 Equity Incentive Plan and the RSA award agreement thereunder (the “Award Documents”), the terms of which shall supersede any inconsistent term of this letter.  Shares subject to this grant shall be scheduled to vest over a four (4) year period according to the following schedule:  Twenty-five percent (25%) of the Award will be scheduled to vest on each of the one, two, three and four year anniversaries of the vesting commencement date, subject to your continued employment with AXT through such applicable vesting period.  Additional grants may be made based on performance at AXT’s discretion.

 

7.

Sign‑on Bonus

Within thirty (30) days following your Start Date, AXT will pay to you a sign‑on bonus in a lump sum cash amount equal to $40,000, less applicable withholdings, and provided that you are employed with AXT on the date such payment is made.     If on or prior to the one-year anniversary of your Start Date either you voluntarily terminate your employment with AXT for any reason or AXT terminates your employment with AXT for Cause (as defined below), you must repay to AXT within thirty (30) days of your termination of employment the gross amount of the sign-on bonus.

 

8.

Annual Bonus Eligibility

You will be eligible to participate in bonus plans as approved for your position by AXT.  For AXT’s fiscal year 2017, your annual target bonus opportunity will be fifty percent (50% )  of your Base Salary (excluding any Salary Premium), which will be prorated based on the number of days that you are employed with AXT during the year.  AXT bonuses are linked to AXT’s financial performance and other performance metrics.  Bonuses typically are considered on a quarterly basis , but ultimately are determined by the Board or its Compensation Committee, in their respective discretion.

 

 

 

 

9.

Tax Equalization

In the event that you become liable for income taxes in China as a result of your employment with AXT during the Assignment Period, AXT will provide tax equalization   for your tax years covering the Assignment Period so that your aggregate tax liability equals the amount of your US taxes disregarding any China taxes. 

 

10.

Business Travel

You will be required to travel to our Tongmei facility in China to fulfill your job duties and to customer sites in Asia, Europe, North America and elsewhere.  You will be entitled to reimbursement by AXT for such customary, ordinary, and usual business expenses.

 

11.

Home Trip

You are eligible to receive up to twelve (12), round‑trip airplane tickets paid by AXT for travel for yourself between China and your California residence each year during the Assignment Period.  A maximum of three (3) of such round‑trip tickets per year may be used by members of your immediately family.  (The cost of family member trips are considered taxable income to you.)  These benefits are contingent on your continuing to remain an employee with AXT through the completion of each such trip. 

 

12.

Other Benefits

 


 

Exhibit 10.1

Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin

 

You will be eligible for health insurance on the first day of the first complete month of your employment.  You will be eligible for our 401 (k) plan after ninety (90 )  days from your Start Date.  You will be eligible for four (4) weeks of vacation per year, subject to AXT’s vacation policy (including any limitations on accrual) as may be in effect and amended from time to time.  Eligibility for additional benefits will commence on your Start Date unless there is a restriction within that benefit. AXT reserves the right to modify or terminate its benefit plans and programs it offers to its employees at any time and from time to time as it deems necessary or appropriate.

 

13.

Involuntary Termination

In the event that your employment with AXT is terminated by AXT without Cause (as defined in Appendix A attached to this letter) and not as a result of your death or Disability (as defined in Appendix A attached to this letter), then subject to your entering into and not revoking a standard separation agreement and release of claims in favor of AXT as described further in Appendix A attached hereto (“Release”), you will receive the following benefits:  (a) a lump sum   cash payment equal to twelve (12) months of your Base Salary (excluding any Salary Premium) in effect on the date of termination of your employment with AXT (“Salary Severance”), and (b) provided that you timely elect to continue coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), for yourself and any of your eligible dependents under AXT’s group health insurance plans following the termination of your employment with AXT, then AXT will pay the COBRA premiums necessary to continue your group health insurance coverage for yourself and your eligible dependents as in effect immediately prior to such termination of your employment until the earliest of (x) twelve (12) months following the termination of your employment with AXT (the “Payment Period”), (y) the expiration of your eligibility for continuation coverage under COBRA, or (z) the date when you become eligible for health insurance coverage in connection with other employment, if any (the “COBRA Benefit”).  Notwithstanding the foregoing under this Section, if AXT determines in its sole discretion that it cannot provide the COBRA Benefit without potentially violating, or being subject to an excise tax under, applicable law (including, without limitation, Section 2716 of the Public Health Service Act and ERISA), then in lieu thereof, AXT will provide to you a taxable lump sum payment in an amount equal to the monthly COBRA premium that you would be required to pay to continue the group health coverage in effect on the date of termination of your employment with AXT (which amount will be based on the premium for the first month of COBRA coverage) for the Payment Period, which payment will be made regardless of whether you (and/or any eligible dependents) elects COBRA continuation coverage.  For the avoidance of doubt, any taxable payments described in this Section may be used for any purpose, including, but not limited to, COBRA continuation coverage, and will be subject to all applicable withholdings.

 

In the event that your employment with AXT is terminated by AXT without Cause and such termination occurs upon or within twelve (12) months following a Change in Control, as such term is defined in AXT’s 2015 Equity Incentive Plan, then subject to your entering into and not revoking the Release, and in addition to the Salary Severance and COBRA Benefit described in the immediately preceding paragraph, any unvested and outstanding portion of your then outstanding equity award s   will accelerate vesting in full. 

 

14.

Withholdings

AXT will withhold from any payments or benefits under this letter any applicable U.S. federal, state and local and non‑U.S. taxes required to be withheld and any other required payroll deductions.

 

15.

Additional Conditions

Additional terms and conditions applicable to this letter are set forth in the Appendix A attached hereto, which is incorporated herein by reference and made a part of this letter.

 

16.

Outside Activities

While employed by AXT, and unless otherwise agreed in writing, you agree that you will not undertake any other form of employment or other activity that may negatively affect the performance of your duties as an employee of AXT.  Further, you agree that you will not directly or indirectly engage or assist any person or third party in engaging in any business competitive with the business of AXT or any subsidiary or affiliate of AXT. 

 

17.

Your Part in Corporate Governance

 


 

Exhibit 10.1

Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin

 

You will be required to sign AXT’s Proprietary Information and Inventions Agreement which, among other matters, acknowledges that you received, read and agree to diligently adhere to and support AXT’s policies including AXT’s:

Ø Code of Business Conduct and Ethics

Ø Insider Trading Policy

Ø Related Party Transactions

Ø International Bribery known as the Foreign Corrupt Practices Act

Ø Employee Handbook

 

18.

Protected Activity

You understand that nothing in this letter or the Proprietary Information and Inventions Agreement shall in any way limit or prohibit you from engaging for a lawful purpose in any Protected Activity.  For purposes of this letter and the Proprietary Information and Inventions Agreement, “Protected Activity” shall mean filing a charge, complaint, or report with, or otherwise communicating with, cooperating with or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (“Government Agencies”).  You understand that in connection with such Protected Activity, you are permitted to disclose documents or other information as permitted by law, and without giving notice to, or receiving authorization from, AXT. Notwithstanding the foregoing, you agree to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute AXT confidential information under the Proprietary Information and Inventions Agreement (or any other non‑disclosure agreement) to any parties other than the relevant Government Agencies. You further understand that “Protected Activity” does not include the disclosure of any AXT attorney-client privileged communications, and that any such disclosure without AXT’s written consent shall constitute a material breach of this letter and the Proprietary Information and Inventions Agreement.  In addition, pursuant to the Defend Trade Secrets Act of 2016, you are notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal.  Further, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.

 

19.

Termination of Employment

You understand and agree that employment with AXT is for no specific period of time.  Your employment with AXT is “at will,” meaning that either you or AXT may terminate your employment at any time and for any reason, with or without cause.  No person at AXT has the authority to modify or change the at will nature of your employment except AXT’s CEO and any such modification or change must be in writing, signed by the CEO.

 

AXT’s total liability to you in the event of termination of your employment is limited to the payment of your salary and other earned compensation through the effective date of termination including accrued vacation and any valid expense reports outstanding and if applicable, any severance payments and benefits payable under Section  ‎13  above, subject to the terms and conditions set forth herein. 

20.

Governing Law and Arbitration 

Your rights and obligations as an employee of AXT will be governed by the laws of the State of California without regard to the conflict-of-law provisions thereof.  Any unresolved dispute, claim, or controversy arising out of or related to your employment with AXT or the termination of that employment shall be resolved exclusively through final and binding arbitration.  The location of the arbitration shall be Alameda County or San Francisco, California.

 

 


 

Exhibit 10.1

Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin

 

21.

Miscellaneous

This letter (including, for the avoidance of doubt, Appendix A attached hereto), together with the Proprietary Information and Inventions Agreement as well as the Award Documents, represents the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral.  No waiver, alteration, or modification of any of the provisions of this letter will be binding unless in writing and signed by duly authorized representatives of the parties hereto.  In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this letter will continue in full force and effect without said provision.  Headings in this letter are for purposes of reference only and will not limit or otherwise affect the meaning hereof.

 

 

Wilson, we are very pleased to make this offer to you and look forward to you joining the AXT team.  This offer expires on July 24, 2017, at 5:00 pm.  Please sign the enclosed copy of this letter and return it to me as soon as possible.

 

Very truly yours,

 

 

/s/ MORRIS S. YOUNG

Dr. Morris Young

Chief Executive Officer

 

 

 

 

 

 

Offer Accepted:

 

 

Signature

/s/ WILSON LIN

July 14, 2017   

Printed Name

Dr. Wilson Lin

Date

Intended Start Date:    09/01/2017 ____________________

 

 

 

 

APPENDIX A

 

ADDITIONAL PROVISIONS

 

A.

Definitions    

(1) Cause .”  For purposes of the letter to which this Appendix A is attached (the “Letter”), “Cause” means (i) any act of personal dishonesty taken by you in connection with your duties and responsibilities as an employee and intended to result in your substantial personal enrichment, (ii) the conviction of a felony which the Board reasonably believes had or will have a material detrimental effect on the Company's reputation or business, (iii) a willful act by you that constitutes gross misconduct and which results in material harm to AXT’s reputation or business, and (iv) continued violations by you of your obligations which are demonstrably willful and deliberate on your part after there has been delivered to you a written demand for performance from AXT that describes the basis for AXT’s belief that you have not substantially performed your duties.

 


 

Exhibit 10.1

Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin

 

(2) Disability .”  For purposes of the Letter, “Disability” means total and permanent disability as defined in Section 22(e)(3) of the Internal Revenue Code of 1986, as amended (the “Code”).

 

B.

Separation and Release of Claims Agreement    

The receipt of any severance payments and benefits under the Letter (“Severance Benefits”) is subject to your timely signing and not revoking the Release, which must become effective and irrevocable no later than the sixtieth (60 th ) day following the termination of your employment (the “Release Deadline Date”).  If the Release does not become effective and irrevocable by the Release Deadline Date, you will forfeit any right to the Severance Benefits.  In no event will Severance Benefits be paid or provided, or in the case of any installments, begin until the Release actually becomes effective and irrevocable.  If the Release becomes effective and irrevocable by the Release Deadline Date, then subject to Sections   and   below, the Severance Benefits will be paid, or in the case of installments, will begin, on the first normally scheduled payroll date of AXT immediately after the date that the Release becomes effective and irrevocable, provided that if the Release Deadline Date occurs in the calendar year following the calendar year in which the termination of your employment occurs, then the Severance Benefits will be paid, or in the case of installments, will begin, on the later of (1) the first normally scheduled payroll date of AXT occurring immediately after the date on which the Release becomes effective and irrevocable, or (2) the first normally scheduled payroll date of AXT occurring immediately after the calendar year in which the termination of your employment occurred (such payment date, the “Severance Start Date”), but in no event later than March 15th of the calendar year following the calendar year in which the termination of your employment occurs, and any Severance Benefits otherwise payable to you during the period immediately following the termination of your employment with AXT through the Severance Start Date will be paid in a lump sum to you on the Severance Start Date, with any remaining payments to be made as provided in the Letter (or this Appendix A , as applicable). 

 

C.

Limitations on Payments    

(1) Best Results .  In the event that the payments and benefits provided for in the Letter or other payments and benefits payable or provided to you (i) constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) but for this Section  ‎C , would be subject to the excise tax imposed by Section 4999 of the Code, then your payments and benefits under the Letter or other payments or benefits (the “ 280G Amounts ”) will be either: (1) delivered in full; or (2) delivered as to such lesser extent that would result in no portion of the 280G Amounts being subject to the excise tax under Section 4999 of the Code; whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by you on an after-tax basis, of the greatest amount of 280G Amounts, notwithstanding that all or some portion of the 280G Amounts may be taxable under Section 4999 of the Code.

 

 


 

Exhibit 10.1

Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin

 

(2) Reduction Order .  In the event that a reduction of 280G Amounts is made in accordance with Section  ‎C , the reduction will occur, with respect to the 280G Amounts considered parachute payments within the meaning of Section 280G of the Code, in the following order:

(a) reduction of cash payments in reverse chronological order (that is, the cash payment owed on the latest date following the occurrence of the event triggering the excise tax will be the first cash payment to be reduced);

(b) cancellation of equity awards that were granted “contingent on a change in ownership or control” within the meaning of Code Section 280G in the reverse order of date of grant of the awards (that is, the most recently granted equity awards will be cancelled first);

(c) reduction of the accelerated vesting of equity awards in the reverse order of date of grant of the awards (that is, the vesting of the most recently granted equity awards will be cancelled first); and

(d) reduction of employee benefits in reverse chronological order (that is, the benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first benefit to be reduced).

In no event will you have any discretion with respect to the ordering of payment reductions.

(3) Firm .  Unless AXT and you otherwise agree in writing, any determination required under this Section  ‎C  will be made in writing by a nationally recognized accounting or valuation firm (the “Firm”) selected by AXT, whose determination will be conclusive and binding upon you and AXT for all purposes.  For purposes of making the calculations required by this Section  ‎C , the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code.  AXT and you will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this Section  ‎C .  AXT will bear the costs and make all payments for the Firm’s services in connection with any calculations contemplated by this Section  ‎C .

 

D.

Section 409A    

 

(1) Notwithstanding anything to the contrary in the Letter or this Appendix A , no Severance Benefits to be paid or provided to you, if any, when considered together with any other severance payments or separation benefits, are considered deferred compensation under Section 409A of the Code, and the final regulations and any guidance promulgated thereunder (“ Section 409A ”) (together, the “ Deferred Payments ”) will be paid or otherwise provided until you have a “separation from service” within the meaning of Section 409A.  Similarly, no Severance Benefits payable to you, if any, that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A‑1(b)(9) will be payable until you have a “separation from service” within the meaning of Section 409A. 

 

 


 

Exhibit 10.1

Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin

 

(2) It is intended that none of the Severance Benefits will constitute Deferred Payments but rather will be exempt from Section 409A as a payment that would fall within the “short-term deferral period” as described in subsection (4) below or resulting from an involuntary separation from service as described in subsection (5) below.  In no event will you have discretion to determine the taxable year of payment of any Deferred Payment.

 

(3) Notwithstanding anything to the contrary in the Letter or this Appendix A , if you are a “specified employee” within the meaning of Section 409A at the time of your separation from service (other than due to death), then the Deferred Payments, if any, that are payable within the first six (6) months following your separation from service, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of your separation from service.  All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.  Notwithstanding anything herein to the contrary, in the event of your death following your separation from service, but before the six (6) month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of your death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit.  Each payment and benefit payable under the Letter and this Appendix A is intended to constitute a separate payment under Section 1.409A‑2(b)(2) of the Treasury Regulations.

 

(4) Any amount paid under the Letter or this Appendix A that satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute Deferred Payments for purposes of subsection (1) above.

 

(5) Any amount paid under the Letter or this Appendix A that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A‑1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit (as defined below) will not constitute Deferred Payments for purposes of subsection (1) above.

 

(6) Any reimbursement or in‑kind benefit not otherwise exempt from Section 409A will be subject to the following requirements:  (a) the amount of expenses eligible for reimbursement or in‑kind benefits provided during one year will not affect the expenses eligible for reimbursement or in‑kind benefits provided during any other year; (b) the reimbursement of an eligible expense is made on or before the last day of the year following the year in which the expense is incurred; and (c) the right to reimbursement or in‑kind benefits is not subject to liquidation or exchange for another benefit.

 

(7) The foregoing provisions are intended to comply with or be exempt from the requirements of Section 409A so that none of the Severance Benefits will be subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to so comply or be exempt.  For purposes of the Letter and this Appendix A ,   to the extent required to be exempt from or comply with Section 409A, references to the “termination of your employment” or similar phrases will be references to your “separation from service” within the meaning of

 


 

Exhibit 10.1

Employment Offer Letter, dated as of July 10, 2017, between AXT, Inc. and Wilson Lin

 

Section 409A.  AXT and you agree to work together in good faith to consider amendments to the Letter and this Appendix A and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition before actual payment to you under Section 409A.  In no event will AXT reimburse you for any taxes imposed or other costs incurred as result of Section 409A.

 

(8) For purposes of the Letter, “Section 409A Limit” will mean two (2) times the lesser of: (a) your annualized compensation based upon the annual rate of pay paid to you during your taxable year preceding your taxable year of your termination of employment as determined under, and with such adjustments as are set forth in, Treasury Regulation Section 1.409A‑1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto; or (b) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which your employment is terminated.  

 

*     *     *

 

 


 

 

PICTURE 1

Exhibit 99.1

AXT Press Release, dated August 22, 2017

 

 

 

 

 

 

 

 

FOR IMMEDIATE RELEASE

 

Contact:

Gary Fischer

Chief Financial Officer

(510) 438-4700

 

AXT Appoints Wilson Lin as Chief Operating Officer

 

FREMONT, Calif., August 22, 2017 – AXT, Inc. (NasdaqGS: AXTI), a leading manufacturer of compound semiconductor substrates, today announced that it has appointed Wilson Lin, Ph.D., 48, as chief operating officer, effective August 21, 2017. Lin will have responsibility for AXT’s global operations and will report to chief executive officer, Morris Young.

 

Over the course of his career, Lin has built a solid track record of success in operations and business management in the compound semiconductor and related industries. Before joining AXT, he served as director and CEO of General Photonics Corporation, a manufacturer of advanced optical polarization modules and instruments.  At General Photonics, he reorganized the global sales channels and launched new programs in operations, including six-sigma manufacturing processes.  Prior to General Photonics, Lin held various management positions of increasing responsibility at Newport Corporation, a worldwide leader in photonics solutions.  He joined Newport in December 2006 as director, global supply chain management, where he consolidated Newport's global supply chain, with a focus on creating efficiencies and reducing material costs.  In February 2010, Lin was appointed as general manager of China Operations.  In this role, he successfully established a China manufacturing facility that employed approximately 200 people and supplied components and subsystems to tier-one customers in the medical, semiconductor and telecom industries.  In January 2013, Lin was appointed as vice president, Asia Pacific, and became responsible for all operations, engineering, marketing, sales and services for Newport in the Asia Pacific region.  He initiated and led region-wide changes, including the restructuring of the sales channels, to drive organic growth.  Overcoming challenges from both domestic and international competitors, Lin and his team achieved wins on critical projects in the region and strengthened relationships with high-level decision makers of key customers.

 

“I am delighted to announce that Wilson Lin has joined our executive team,” said Morris Young, chief executive officer. “Wilson has a solid track record of demonstrating expanding responsibility and achievement. His business skills and broad experience in China, as well as his deep understanding of single crystal growth technology, will combine to bring a very positive contribution to AXT. This is an exciting addition to our team and comes at an exciting time in our business growth.”

 

 


 

 

 

 

 

 

 

 

 

Exhibit 99.1

AXT Press Release, dated August 22, 2017

 

Lin holds a Ph.D. in physics from the City University of New York and conducted postdoctoral research at Princeton University.  He has published more than 30 technical articles related to crystal growth and the fabrication of compound semiconductors and their applications.  Further, Lin earned an M.B.A. degree from the UCLA Anderson School of Management and a B.S. degree in physics from Chun-Yuan University, Taiwan.

 

 

About AXT, Inc.

 

AXT designs, develops, manufactures and distributes high-performance compound and single element semiconductor substrates comprising indium phosphide (InP), gallium arsenide (GaAs) and germanium (Ge) through its manufacturing facilities in Beijing, China.  In addition, AXT maintains its sales, administration and customer service functions at its headquarters in Fremont, California.  The company’s substrate products are used primarily in lighting display applications, wireless communications, fiber optic communications and solar cell applications. Its vertical gradient freeze (VGF) technique for manufacturing semiconductor substrates provides significant benefits over other methods and enabled AXT to become a leading manufacturer of such substrates. AXT has manufacturing facilities in China and invests in joint ventures in China producing raw materials. For more information, see AXT’s website at http://www.axt.com .

 

Safe Harbor Statement

 

The foregoing paragraphs contain forward-looking statements within the meaning of the Federal securities laws, including, for example, statements about our business growth and the expected contribution that Dr. Lin will provide. These forward-looking statements are based upon assumptions that are subject to uncertainties and factors relating to the company’s operations and business environment, which could cause actual results to differ materially from those expressed or implied in the forward-looking statements contained in the foregoing discussion. These uncertainties and factors include but are not limited to: the ability of Dr. Lin to contribute effectively, overall conditions in the markets in which the company competes; global financial conditions and uncertainties; policies and regulations in China; the relocation of the company’s manufacturing operations in China; market acceptance and demand for the company’s products; the impact of factory closures or other events causing delays by our customers on the timing of sales of our products; our ability to control costs, our ability to utilize our manufacturing capacity; product yields and their impact on gross margins; and other factors as set forth in the company’s Annual Report on Form 10-K, quarterly reports on Form 10-Q and other filings made with the Securities and Exchange Commission.  Each of these factors is difficult to predict and many are beyond the company’s control. The company does not undertake any obligation to update any forward-looking statement, as a result of new information, future events or otherwise.